Page last updated: 2024-09-02

1-hexadecyl-2-acetyl-glycero-3-phosphocholine and bradykinin, 1-adamantanecarboxylic acid-arg(0)-hyp(3)-thi(5,8)-phe(7)-

1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with bradykinin, 1-adamantanecarboxylic acid-arg(0)-hyp(3)-thi(5,8)-phe(7)- in 1 studies

Compound Research Comparison

Studies
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)
Trials
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)
Recent Studies (post-2010)
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)
Studies
(bradykinin, 1-adamantanecarboxylic acid-arg(0)-hyp(3)-thi(5,8)-phe(7)-)
Trials
(bradykinin, 1-adamantanecarboxylic acid-arg(0)-hyp(3)-thi(5,8)-phe(7)-)
Recent Studies (post-2010) (bradykinin, 1-adamantanecarboxylic acid-arg(0)-hyp(3)-thi(5,8)-phe(7)-)
9,156187552910

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dear, JW; Foreman, JC; Turner, PJ1

Trials

1 trial(s) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and bradykinin, 1-adamantanecarboxylic acid-arg(0)-hyp(3)-thi(5,8)-phe(7)-

ArticleYear
Involvement of kinins in hyperresponsiveness induced by platelet activating factor in the human nasal airway.
    British journal of pharmacology, 2000, Volume: 129, Issue:3

    Topics: Adamantane; Adult; Area Under Curve; Blood Proteins; Bradykinin; Bradykinin Receptor Antagonists; Eosinophil Granule Proteins; Histamine Release; Humans; Kinins; Middle Aged; Nasal Cavity; Platelet Activating Factor; Receptor, Bradykinin B2; Ribonucleases; Therapeutic Irrigation

2000